ARQT vs ITGR: Which Stock Is the Better Buy?
Arcutis Biotherapeutics, Inc. and Integer Holdings Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — ARQT vs ITGR, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Arcutis Biotherapeutics, Inc. (ARQT) | Integer Holdings Corporation (ITGR) | |
|---|---|---|
| Market cap | $3.0B | $3.1B |
| Revenue (latest FY) | $376.07M | $1.85B |
| Net income (latest FY) | $-16.14M | $102.81M |
| Revenue growth (5y CAGR) | — | 11.5% |
| Net margin | -4.3% | 5.5% |
| Return on equity | -8.5% | 5.9% |
| P/E ratio | — | 22.9 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 10 |
| Positive free cash flow | No | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full ARQT vs ITGR breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open ARQT's full financials → Open ITGR's full financials →More comparisons
Frequently asked questions
Which is bigger, ARQT or ITGR?
Integer Holdings Corporation is larger by market capitalization — $3.1B versus $3.0B.
Which grows faster, ARQT or ITGR?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.